These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 32325147)
1. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation. Li LY; Lou Q; Liu GZ; Lv JC; Yun FX; Li TK; Yang W; Zhao HY; Zhang L; Bai N; Zhan CC; Yu J; Zang YX; Li WM Eur J Pharmacol; 2020 Aug; 881():173120. PubMed ID: 32325147 [TBL] [Abstract][Full Text] [Related]
2. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation. Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577 [TBL] [Abstract][Full Text] [Related]
3. Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats. Li Q; Fang Y; Peng DW; Li LA; Deng CY; Yang H; Kuang SJ; Li QQ; Zhang MZ; Zeng P; Zhang QH; Liu Y; Deng H; Wei W; Xue YM; Wu SL; Rao F Eur J Pharmacol; 2023 Aug; 952():175754. PubMed ID: 37182595 [TBL] [Abstract][Full Text] [Related]
4. An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation. Tajiri K; Guichard JB; Qi X; Xiong F; Naud P; Tardif JC; Costa AD; Aonuma K; Nattel S Cardiovasc Res; 2019 Dec; 115(14):1975-1985. PubMed ID: 31119260 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation. Hesselkilde EZ; Carstensen H; Flethøj M; Fenner M; Kruse DD; Sattler SM; Tfelt-Hansen J; Pehrson S; Braunstein TH; Carlson J; Platonov PG; Jespersen T; Buhl R BMC Cardiovasc Disord; 2019 Oct; 19(1):228. PubMed ID: 31638896 [TBL] [Abstract][Full Text] [Related]
7. Sacubitril/valsartan attenuates atrial structural remodelling in atrial fibrillation patients. Yang L; Zhang M; Hao Z; Wang N; Zhang M ESC Heart Fail; 2022 Aug; 9(4):2428-2434. PubMed ID: 35437929 [TBL] [Abstract][Full Text] [Related]
8. Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation. Lou Q; Li L; Liu G; Li T; Zhang L; Zang Y; Zhan C; Wang H; Li W J Cardiovasc Pharmacol Ther; 2023; 28():10742484231185252. PubMed ID: 37403470 [No Abstract] [Full Text] [Related]
9. Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing. Yang Q; Qi X; Dang Y; Li Y; Song X; Hao X BMC Cardiovasc Disord; 2016 Jun; 16(1):142. PubMed ID: 27342818 [TBL] [Abstract][Full Text] [Related]
10. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties. Ma J; Ma S; Yin C; Wu H J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366 [TBL] [Abstract][Full Text] [Related]
11. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887 [TBL] [Abstract][Full Text] [Related]
12. [Effect of sacubitril/valsartan on cardiac function in heart failure rabbits with preserved ejection fraction]. Gao SY; Yao DH; Li JF; Xie QM; Jiang SC Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):887-893. PubMed ID: 31744278 [No Abstract] [Full Text] [Related]
13. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease. Hiram R; Xiong F; Naud P; Xiao J; Sirois M; Tanguay JF; Tardif JC; Nattel S Cardiovasc Res; 2021 Jun; 117(7):1776-1789. PubMed ID: 32866246 [TBL] [Abstract][Full Text] [Related]
14. Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model. Zhao Z; Chen Y; Li W; Wang X; Li J; Yang W; Cheng L; Liu T; Liu E; Li G Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):863-71. PubMed ID: 27118660 [TBL] [Abstract][Full Text] [Related]
15. Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway. Liu GZ; Hou TT; Yuan Y; Hang PZ; Zhao JJ; Sun L; Zhao GQ; Zhao J; Dong JM; Wang XB; Shi H; Liu YW; Zhou JH; Dong ZX; Liu Y; Zhan CC; Li Y; Li WM Br J Pharmacol; 2016 Mar; 173(6):1095-109. PubMed ID: 26787506 [TBL] [Abstract][Full Text] [Related]
16. Qiliqiangxin attenuates atrial structural remodeling in prolonged pacing-induced atrial fibrillation in rabbits. Tingting H; Guangzhong L; Yanxiang Z; DongDong Y; Li S; Li W Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):585-592. PubMed ID: 30627756 [TBL] [Abstract][Full Text] [Related]
18. Effect of Na+-channel blockade on the three-dimensional substrate of atrial fibrillation in a model of endo-epicardial dissociation and transmural conduction. Gharaviri A; Verheule S; Eckstein J; Potse M; Krause R; Auricchio A; Kuijpers NHL; Schotten U Europace; 2018 Nov; 20(suppl_3):iii69-iii76. PubMed ID: 30476060 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Liu T; Zhao H; Li J; Korantzopoulos P; Li G Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats. Zhang K; Ma Z; Wang W; Liu R; Zhang Y; Yuan M; Li G Cardiovasc Ther; 2018 Dec; 36(6):e12466. PubMed ID: 30203914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]